RecruitingNCT07325864

Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site

Sponsor

European Institute of Oncology

Enrollment

25 participants

Start Date

Dec 18, 2025

Study Type

OBSERVATIONAL

Conditions

investigate the molecular differences between primitive lung cancer and the metastatic site.

Min Age: 18 Years

patients aged ≥18 years fit enough to tolerate the surgical operation;
the operative risk is considered low based on respiratory reserve and cardiac assessment;
the patient has clearly expressed willingness to adhere;
availability of pathological material for tumor DNA extraction and NGS execution.

Women of childbearing age, pregnant or breastfeeding, or intending to become pregnant during the study.
Any other illness, metabolic disorder, physical examination, or laboratory findings that constitute a contraindication to study participation.
Recent or ongoing severe or clinically significant infection.

Istituto Europeo di Oncologia

Milan, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

NCT07325864